Domestic wastewater (DWW) contains a reservoir of nutrients, such as nitrogen, potassium, and phosphorus; however, emerging micropollutants (EMPs) hinder its applications in resource recovery. In this study, a novel class of nanofiltration (NF) membranes was developed; it enabled the efficient removal of harmful EMP constituents while preserving valuable nutrients in the permeate. Neutral (IM-N) and positively charged (IM-P) imidazole derivative compounds have been used to chemically functionalize pristine polyamide (PA) membranes to synchronously inhibit the hydrolysis of residual acyl chloride and promote their amination. Owing to their distinct properties, these IM modifiers can custom-build the membrane physicochemical properties and structures to benefit the NF process in DWW treatment. The electroneutral NF membrane exhibited ultrahigh solute-solute selectivity by minimizing the Donnan effects on ion penetration (K, N, and P ions rejection < 25%) while imposing remarkable size-sieving obstruction against EMPs (rejection ratio > 91%). Moreover, the hydrophilic IM-modifier synergistically led to enhanced water permeance of 9.2 L m h bar, reaching a 2-fold higher magnitude than that of the pristine PA membrane, along with excellent antifouling/antibacterial fouling properties. This study may provide a paradigm shift in membrane technology to convert wastewater streams into valuable water and nutrient resources.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.watres.2023.119567DOI Listing

Publication Analysis

Top Keywords

imidazole derivative
8
solute-solute selectivity
8
unveiling impact
4
impact imidazole
4
derivative mechanistic
4
mechanistic insights
4
insights neutralize
4
neutralize interfacial
4
interfacial polymerized
4
polymerized membranes
4

Similar Publications

The present study reveals an unexpected anomaly observed in the acid-catalyzed hydrolysis of the 5,6-O-isopropylidene group in 3-O-protected D-gluco- and D-allofuranose derivatives. Although the removal of the 5,6-O-isopropylidene protecting group is typically rapid and quantitative under acidic conditions, an unexpected inhibition of this reaction is observed for the two C3-epimers, 3-O-imidazole sulfonyl moiety. X-ray data show a two-faced imidazole ring orientation in the crystal, while solution state NOE data reveal a critical interaction type between the isopropylidene and the imidazole rings.

View Article and Find Full Text PDF

Differentiation therapy with all-trans retinoic acid (ATRA) is well established for acute promyelocytic leukemia (APL). However, the narrow application and tolerance development of ATRA remain to be improved. A number of kinase inhibitors have been reported to induce cell differentiation.

View Article and Find Full Text PDF

This study presents a comprehensive exploration of the synthesis of novel compounds targeting Chagas Disease (CD) caused by Trypanosoma cruzi. It is a global health threat with over 6-7 million infections worldwide. Addressing challenges in current treatments, the investigation explores diverse compound classes, including thiazoles, thiazolidinone, imidazole, pyrazole, 1,6-diphenyl-1H-pyrazolo[3,4-b] pyridine, pyrrole, naphthoquinone, neolignan, benzeneacyl hydrazones, and chalcones-based compounds.

View Article and Find Full Text PDF

This study explores the design, synthesis, and evaluation of a novel series of isobenzofuran-based imidazo[2,1-b][1,3,4]thiadiazole derivatives, targeting their antimicrobial and anticancer properties. These compounds integrate the pharmacologically significant 1,3,4-thiadiazole and imidazole moieties, which are known for their potential in drug development, although imidazo[2,1-b][1,3,4]thiadiazole-based drugs are not yet available on the market. Therefore, the aim of this study is to develop novel derivatives that could serve as promising candidates for future therapeutic applications.

View Article and Find Full Text PDF

Background: In TALAPRO-2, the poly(ADP-ribose) polymerase inhibitor talazoparib plus the androgen receptor-signaling inhibitor enzalutamide improved radiographic progression-free survival (rPFS) versus placebo plus enzalutamide (hazard ratio [HR] = 0.63; 95% CI, 0.51-0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!